Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.84565 | 36 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.77482 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.78488 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.71471 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.71885 | 34 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.88848 | 36 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.83013 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.75619 | 34 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.74417 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.75337 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.76614 | 34 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.73604 | 34 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.77152 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.77235 | 34 |